About this event
The overall healthcare ecosystem is moving towards small set-ups from larger & complex set-ups, lead by innovations in the area of home-based diagnostics, remote screening and monitoring solutions, and telehealth. A major focus of innovation has been the miniaturization of different sub-components to make the diagnostic & monitoring devices portable, accurate, and economical, along with real-time analysis/output.
An increasing shift towards home care, early detection, less invasive procedures, and cost efficiency among other drivers are further fueling the need for point-of-care low-cost diagnostic devices and equipment. Technology, chemicals, semiconductors, and material players are busy answering unmet needs through miniaturization. These players are using exponential & incremental technologies like AI/ML, 3D printing, IoT, synthetic biology, nanoelectronics, microfluidics, etc., to improve the competitiveness of their existing product offerings and deliver disruptive products. Apart from reducing size for large diagnostic/imaging products, miniaturized diagnostic solutions are also being integrated with products like smart wearables, mobile accessories, etc. which are eventually connected to electronic health records (EHR).
Join our webinar to understand:
Hosted by
A Medtech strategist with a keen interest in novel therapy areas, digitalization, and medical nutrition segments
I'm passionate about technology innovation and how it will shape the Future of the Life Sciences industry. I work with the client stakeholders from R&D, Innovation, Strategy, and BD&L to provide deep techno-commercial insights.
FutureBridge is a techno-commercial consulting and advisory company.
We track and advise on the future of industries from a 1-to-25-year perspective to keep you ahead of the technology curve, propel your growth, Identify new opportunities, markets and business models, answer your unknowns, and fac